References

cardiovascular

Кардиоваскулярная терапия и профилактика

Cardiovascular Therapy and Prevention

1728-88002619-0125

«SILICEA-POLIGRAF» LLC

10.15829/1728-8800-2019-2272

cardiovascular-2369

Research Article

ОБЗОРЫ ЛИТЕРАТУРЫ

REVIEW ARTICLES

Стратификация предоперационного риска у больных пожилого возраста в кардиохирургической клинике

Stratification of preoperative risk in elderly patients in cardiac surgery clinic

https://orcid.org/0000-0002-8823-8683

Гайфулин

Р. А.

Gaifullin

R. A.

Гайфулин Руслан Анфальевич — доктор медицинских наук, научный сотрудник лаборатории интервенционных методов диагностики и лечения отдела мультифокального атеросклероза.

Кемерово, Тел.: +7 (3842) 64-38-89, моб. +7 (903) 993-05-03

Kemerovo

rus_gayf@mail.ru

https://orcid.org/0000-0002-9070-5527

Иванов

С. В.

Ivanov

S. V.

Иванов Сергей Васильевич — доктор медицинских наук, ведущий научный сотрудник лаборатории реконструктивной хирургии мультифокального атеросклероза отдела мультифокального атеросклероза.

Кемерово

Kemerovo

https://orcid.org/0000-0002-3776-9361

Гайфулина

Е. Н.

Gaifullina

E. N.

Гайфулина Екатерина Николаевна — кандидат медицинских наук, лаборант-исследователь отдела организации инновационных и клинических исследований.

Кемерово

Kemerovo

ФГБНУ Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеванийResearch Institute for Complex Issues of Cardiovascular Diseases

2020

20042020

19222722272

2020

Гайфулин Р.А., Иванов С.В., Гайфулина Е.Н.

Gaifullin R.A., Ivanov S.V., Gaifullina E.N.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://cardiovascular.elpub.ru/jour/article/view/2369

В последние десятилетия старение населения создает множество проблем для системы здравоохранения. Наряду с основными факторами риска, включая частоту и тяжесть сопутствующей патологии, пожилые пациенты подвержены развитию состояний, непосредственно связанные с процессом старения, которые в совокупности обуславливают высокую вероятность возникновения неблагоприятных событий и затрудняют стратификацию риска у пациентов, подвергающихся кардиохирургическим вмешательствам. В настоящем обзоре представлены данные по предоперационной стратификации хирургического риска у когорты больных пожилого возраста.

In recent decades, population aging has created many problems for the health care system. Along with the main risk factors, including the frequency and severity of comorbidities, elderly patients are subject to changes associated with the aging. It leads to a high probability of adverse events and make it difficult to stratify the risk of patients undergoing cardiac surgery. This review presents data on the preoperative risk stratification in elderly surgical patients.

пожилой пациенткардиохирургические операциистратификация риска

elderly patientcardiac surgeryrisk stratification

References1

Наумова Л. А., Осипова О. Н. Коморбидность: механизмы патогенеза, клиническое значение. Современные проблемы науки и образования. 2016;5. URL: http://science-education.ru/ru/article/view?id=25301 (дата обращения: 21.03.2019).

Naumova LA, Osipova ON. Comorbidity: pathogenesis mechanisms, clinical significance. Sovremennyye problemy nauki i obrazovaniya. 2016;5. URL: http://science-education.ru/ru/article/view?id=25301 (21 Mar 2019). (In Russ.)

Kernick D, Chew-Graham CA, O’Flynn N. Clinical assessment and management of multimorbidity: NICE guideline. Br J Gen Pract. 2017;67(658):235-6. doi:10.3399/bjgp17X690857.

Тарловская Е. И. Коморбидность и полиморбидность — современная трактовка и насущные задачи, стоящие перед терапевтическим сообществом. Кардиология. 2018;58(9S):29-38. doi: 10.18087/cardio.2562.

Tarlovskaya EI. Comorbidity and polymorbidity — a modern interpretation and urgent tasks facing the therapeutic community. Kardiologiia. 2018;58(9S):29-38. (In Russ.) doi: 10.18087/cardio.2562.

Schiotz ML, Stockmarr A, Host D, et al. Social disparities in the prevalence of multimorbidity — A register-based population study. BMC Public Health. 2017;17(1):422. doi:10.1186/s12889-017-4314-8.

Hajat C, Stein E. The global burden of multiple chronic conditions: A narrative review. Prev Med Rep. 2018;12:284-93. doi:10.1016/j.pmedr.2018.10.008.

Пузырев В. П. Генетические основы коморбидности у человека. Генетика. 2015;51(4):491-502. doi:10.7868/S0016675815040098.

Puzyrev VP. Genetic basis of comorbidity in humans. Genetika. 2015;51 (4):491-502. (In Russ.)

Dodel R. Multimorbidity: concept, epidemiology and treatment. Nervenarzt. 2014;85(4):401-08. doi: 10.1007/s00115-013-3937-y.

Eickhoff M, Schupke S, Khandoga A, et al. Age-dependent impact of the SYNTAX-score on longer-term mortality after percutaneous coronary intervention in an all-comer population. J Geriatr Cardiol. 2018;15(9):559-66. doi:10.11909/j.issn.1671-5411.2018.09.009.

. Bogana Shanmugam V, Wong DT, Rashid H, et al. Bleeding outcomes after non-emergency percutaneous coronary intervention in the very elderly. J Geriatr Cardiol. 2017;14(10):624-31. doi:10.11909/j.issn.1671-5411.201710.005.

Барбараш О. Л., Жидкова И. И., Шибанова И. А. и др. Возрастные особенности коморбидной патологии у пациентов, подвергающихся плановому коронарному шунтированию. Клиническая практика. 2017;3(S):54-60. doi: 10.17816/clinpract8354-60.

Barbarash OL, Zhidkova II, Shibanova IA, et al. Age peculiarities of comorbid pathology in patients undergoing planned coronary bypass grafting. Clinical Practice. 2017;3(S):54-60. (In Russ.) doi: 10.17816/clinpract8354-60.

Luc JGY, Graham MM, Norris CM, et al. Predicting operative mortality in octogenarians for isolated coronary artery bypass grafting surgery: a retrospective study. BMC Cardiovasc Disord. 2017; 17(1):275. doi:10.1186/s12872-017-0706-z.

Гайфулин Р. А., Сумин А. Н., Иванов С. В., Барбараш Л. С. Анализ отдаленных результатов хирургического лечения больных с мультифокальным атеросклерозом в различных возрастных группах. Атеросклероз и дислипидемия. 2017;2:48-57

Gayfulin RA, Sumin AN, Ivanov SV, Barbarash LS. Analysis of the long-term results of surgical treatment of patients with multifocal atherosclerosis in different age groups. Journal of atherosclerosis and dyslipidaemias. 2017;2:48-57 (In Russ.)

Kozlov KL, Bogachev AA. Coronary revascularization in the elderly with stable angina. J Geriatr Cardiol. 2015;12(5):555-68. doi:10.11909/j.issn.1671-5411.2015.05.017.

Самородская И. В. Скрининг в кардиологии. Комплексные проблемы сердечно-сосудистых заболеваний. 2018;7(4):92-100. doi: 10.17802/2306-1278-2018-7-4-92-100.

Samorodskaya IV. Screening in Cardiology. Kompleksnyye problemy serdechno-sosudistykh zabolevaniy. 2018;7(4):92-100. (In Russ.)

Alonso-Moran E, Nuno-Solinis R, Onder G, Tonnara G. Multimorbidity in risk stratification tools to predict negative outcomes in adult population. Eur J Intern Med. 2015;26(3):182-9. doi:10.1016/j.ejim.2015.02.010.

Ad N, Holmes SD, Patel J, et al. Comparison of EuroSCORE II, Original EuroSCORE, and The Society of Thoracic Surgeons Risk Score in Cardiac Surgery Patients. Ann Thorac Surg. 2016;102(2):573-79. doi:10.1016/j.athoracsur.2016.01.105.

O’Brien SM, Feng L, He X, et al. The Society of Thoracic Surgeons 2018 Adult Cardiac Surgery Risk Models: Part 2-Statistical Methods and Results. Ann Thorac Surg. 2018;105(5):1419-28. doi:10.1016/j.athoracsur.2018.03.003.

Qadir I, Alamzaib SM, Ahmad M, et al. EuroSCORE versus EuroSCORE II versus Society of Thoracic Surgeons risk algorithm. Asian Cardiovasc Thorac Ann. 2014;22(2):165-71. doi:10.1177/0218492313479355.

Levine GN, Bates ER, Blankenship JC, et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial Infarction: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2016;87(6):1001-19. doi:10.1002/ccd.26325.

Orkaby AR, Forman DE. Assessing Risks and Benefits of Invasive Cardiac Procedures in Patients with Advanced Multimorbidity. Clin Geriatr Med. 2016; 32(2):359-71. doi:10.1016/j.cger.2016.01.004.

Ikeno F, Brooks MM, Nakagawa K, et al. SYNTAX Score and LongTerm Outcomes: The BARI-2D Trial. JACC. 2017;69(4.):395-403. doi:10.1016/j.jacc.2016.10.067.

Serruys PW, Kogame N, Katagiri Y, et al. Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with three-vessel disease: 2-year follow-up of the SYNTAX II study. Euro Intervention. 2019. pii: EIJ-D-18-00980. doi: 10.4244/EIJ-D-18-00980. [Epub ahead of print].

Lim HS, Tonino PA, De Bruyne B, et al. The impact of age on fractional flow reserve-guided percutaneous coronary intervention: a FAME (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) trial substudy. Int J Cardiol. 2014;177(1):66-70. doi:10.1016/j.ijcard.2014.09.010.

Clegg A, Bates C, Young J, et al. Development and validation of an electronic frailty index using routine primary care electronic health record data. Age Ageing. 2016;45(3):353-60. doi:10.1093/ageing/afw039.

Keevil VL, Romero-Ortuno R. Ageing well: a review of sarcopenia and frailty. Proc Nutr Soc. 2015;74(4):337-47 doi:10.1017/S0029665115002037.

Bibas L, Levi M, Bendayan M, et al. Therapeutic interventions for frail elderly patients: part I. Published randomized trials. Prog Cardiovasc Dis. 2014;57(2):134-43. doi: 10.1016/j.pcad.2014.07.004.

Webb J, Gerosa G, Lefevre T, et al. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. JACC. 2014;64(21):2235-43. doi:10.1016/j.jacc.2014.09.026.

Верткин А. Л., РумянцевМ. А., Скотников А. С. Коморбидность в клинической практике. Часть 2. Архив внутренней медицины. 2011;2:20-24.

Vertkin AL, Rumancev MA, Skotnikov AS. Comorbidity in clinical practice. Arhiv vnutrennej mediciny. 2011;2:20-24. (In Russ.)

Afilalo J, Alexander KP, Mack MJ, et al. Frailty assessment in the cardiovascular care of older adults. JACC. 2014;63(8):747-62. doi:10.1016/j.jacc.2013.09.070. Epub 2013 Nov 27

Finn M, Green P. The Influence of Frailty on Outcomes in cardiovascular Disease. Rev Esp Cardiol (Engl Ed). 2015;68(8):653-6. doi:10.1016/j.rec.2015.04.005.

Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):146-56.

NICE. Multimorbidity: Clinical Assessment and Management. CG56, 2016. https://wwwniceorguk/guidance/ng56 (03 Apr 2019).

Villacampa-Fernandez P, Navarro-Pardo E, Tarin JJ, Cano A. Frailty and multimorbidity: two related yet different concepts. Maturitas. 2017;95:31-5. doi:10.1016/j.maturitas.2016.10.008.

National Institute for Health and Care Excellence. Multimorbidity: clinical assessment and management. NG56. London: NICE, 2016. https://www.nice.org.uk/guidance/ng56 (03 Apr 2019).

Forman DE, Alexander KP. Frailty: a vital sign for older adults with cardiovascular disease. Can J Cardiol. 2016;32(9):1082-7 doi:10.1016/j.cjca.2016.05.015.

Li CM, Chen CY, Li CY, et al. The effectiveness of a comprehensive geriatric assessment intervention program for frailty in communitydwelling older people: a randomized, controlled trial. Arch Gerontol Geriatr. 2010;50(1):39-42. doi:10.1016/S0167-4943(10)70011-X.

Nicholas JA. Preoperative optimization and risk assessment. Clin Geriatr Med. 2014;30(2):207-18. doi: 10.1016/j.cger.2014.01.003.

Huisman MG, Kok M, de Bock GH, et al. Delivering tailored surgery to older cancer patients: preoperative geriatric assessment domains and screening tools-a systematic review of systematic reviews. Eur J Surg Oncol. 2017;43(1): 1 -14. doi: 10.1016/j.ejso.2016.06.003.

Nakhaie M, Tsai A. Preoperative Assessment of Geriatric Patients. Anesthesiol Clin. 2015;33(3):471-80. doi:10.1016/j.anclin.2015.05.005.

Knittel JG, Wildes TS. Preoperative assessment of geriatric patients. Anesthesiol Clin. 2016;34(1 ):171-83. doi: 10.1016/j.anclin.201510.013.

Fairhall N, Kurrle SE, Sherrington C, et al. Effectiveness of a multifactorial intervention on preventing development of frailty in pre-frail older people: study protocol for a randomized controlled trial. BMJ Open. 2015;5(2):e007091. doi:10.1136/bmjopen-2014-007091.

Buta BJ, Walston JD, Godino JG, et al. Frailty assessment instruments: Systematic characterization of the uses and contexts of highly-cited instruments. Ageing Res Rev. 2016;26;53-61. doi:10.1016/j.arr.2015.12.003.

Makary MA, Segev DL, Pronovost PJ, et al. Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg. 2010; 210(6):901-8. doi:10.1016/j.jamcollsurg.2010.01.028.

Lee DH, Buth KJ, Martin BJ, et al. Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery. Circulation. 2010; 121 (8):973-8. doi: 10.1161/CIRCULATIONAHA.108.841437

Sepehri A, Beggs T, Hassan A, et al. The impact of frailty on outcomes after cardiac surgery: a systematic review. J Thorac Cardiovasc Surg. 2014;148(6):3110-7 doi:10.1016/j.jtcvs.2014.07.087.

Romero-Ortuno R, Wallis S, Biram R., Keevil V. Clinical frailty adds to acute illness severity in predicting mortality in hospitalized older adults: An observational study. Eur J Intern Med. 2016;35:24-34. doi:10.1016/j.ejim.2016.08.033.

Sergi G, Veronese N, Fontana L, et al. Pre-frailty and risk of cardiovascular disease in elderly men and women: the pro.v.a. Study. JACC. 2015;65(10):976-83. doi:10.1016/j.jacc.2014.12.040.

Sergi G, Veronese N, Fontana L, et al. Prefrailty and risk of cardiovascular disease in elderly men and women: the pro.v.a. Study. JACC. 2015;65(10):976-83. doi:10.1016/j.jacc.2014.12.040.

Afilalo J, Eisenberg MJ, Morin JF, et al. Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. JACC. 2010; 56(20):1668-76. doi:10.1016/j.jacc.2010.06.039

Stortecky S, Schoenenberger AW, Moser A, et al. Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2012;5(5):489-496. doi:10.1016/j.jcin.2012.02.012.

The authors declare that there are no conflicts of interest present.